Sanofi would implement a "streamlined strategic sales structure" to better support its customers and patients, it said ...
As an Arizonan and mother of three, it has been truly sad to witness recent legislative hearings that have been held and the ...
In key news on French stocks, Sanofi S.A. (FR:SAN) is reportedly planning to revamp its U.S. vaccine operations, including ...
The CDC consistently minimizes COVID, data dashboards have been dismantled, briefings discontinued, and, “Most egregiously, ...
FDA photo. It should be easy for us to understand this fear because we experienced it during the COVID-19 pandemic. With both contagions, vaccines were our saviors. But whereas in the mid ...
This year’s total tally has now outpaced last year’s numbers, with 64 confirmed cases in 17 states so far, compared with 58 in 2023 Measles cases in the US ... stop at measles, but also other ...
In the US, pockets of low measles vaccination are a serious concern: 91 percent of patients infected in the US between 2020 and late March 2024 were unvaccinated or of unknown vaccination status.
Numerous outbreaks of vaccine-preventable diseases have occurred in the United States during the past several years. These outbreaks have occurred on national, regional, and local levels and have ...
Money manager Cathie Wood’s Ark Invest has a favorite biotech holding now, going by the firm’s recent buying activity ... bigger peer and rival COVID-19 vaccine maker Pfizer, Inc. (NYSE ...
Americans thought we had the problem licked, thanks to an aggressive vaccination program for young children starting when a vaccine was developed in the 1960s. In 1971, the measles vaccine was ...